GeneFerm Biotechnology , Ltd. Net Tangible Assets

GeneFerm Biotechnology , Ltd. (1796.TWO) currently reports a net tangible assets of $780M as of June 2026. That compares with $790M in the prior-year period — down 1.3% year over year. Use the charts on this page to explore GeneFerm Biotechnology , Ltd.'s net tangible assets history and peer comparisons.

GeneFerm Biotechnology , Ltd.'s net tangible assets decreased from $790M to $780M — a 1.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GeneFerm Biotechnology , Ltd. reported $780M in net tangible assets as of June 2026. That compares with $790M in the prior-year period — down 1.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $780M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneFerm Biotechnology , Ltd., and consider following 1796.TWO for alerts when major investors trade the stock.